Literature DB >> 23295957

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

An-Wen Chan1, Jennifer M Tetzlaff, Douglas G Altman, Andreas Laupacis, Peter C Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A Berlin, Caroline J Doré, Wendy R Parulekar, William S M Summerskill, Trish Groves, Kenneth F Schulz, Harold C Sox, Frank W Rockhold, Drummond Rennie, David Moher.   

Abstract

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol.The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

Entities:  

Mesh:

Year:  2013        PMID: 23295957      PMCID: PMC5114123          DOI: 10.7326/0003-4819-158-3-201302050-00583

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  39 in total

Review 1.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

Authors:  Karmela Krleza-Jerić; An-Wen Chan; Kay Dickersin; Ida Sim; Jeremy Grimshaw; Christian Gluud
Journal:  BMJ       Date:  2005-04-23

2.  The Good Clinical Practice guideline: a bronze standard for clinical research.

Authors:  David A Grimes; David Hubacher; Kavita Nanda; Kenneth F Schulz; David Moher; Douglas G Altman
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

3.  Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.

Authors:  Sanaa Al-Marzouki; Ian Roberts; Stephen Evans; Tom Marshall
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

4.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

5.  Adverse event reporting in publications compared with sponsor database for cancer clinical trials.

Authors:  Orit Scharf; A Dimitrios Colevas
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

6.  Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.

Authors:  R M D Smyth; J J Kirkham; A Jacoby; D G Altman; C Gamble; P R Williamson
Journal:  BMJ       Date:  2011-01-06

7.  Guidance for developers of health research reporting guidelines.

Authors:  David Moher; Kenneth F Schulz; Iveta Simera; Douglas G Altman
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069

8.  Developing a guideline for clinical trial protocol content: Delphi consensus survey.

Authors:  Jennifer Marie Tetzlaff; David Moher; An-Wen Chan
Journal:  Trials       Date:  2012-09-24       Impact factor: 2.279

9.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Karsten J Jørgensen; Peter C Gøtzsche; Douglas G Altman
Journal:  BMJ       Date:  2008-12-04

10.  Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials.

Authors:  Douglas G Altman; Curt D Furberg; Jeremy M Grimshaw; Peter M Rothwell
Journal:  Trials       Date:  2006-03-23       Impact factor: 2.279

View more
  2000 in total

Review 1.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Authors:  Kanwal Pratap Singh Raghav; Sminil Mahajan; James C Yao; Brian P Hobbs; Donald A Berry; Rebecca D Pentz; Alda Tam; Waun K Hong; Lee M Ellis; James Abbruzzese; Michael J Overman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 2.  The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.

Authors:  Claudia Pansieri; Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2015-08-05       Impact factor: 2.953

3.  Free for service: the inadequate incentives for quality peer review.

Authors:  Joseph Bernstein
Journal:  Clin Orthop Relat Res       Date:  2013-08-08       Impact factor: 4.176

4.  The Ontology of Clinical Research (OCRe): an informatics foundation for the science of clinical research.

Authors:  Ida Sim; Samson W Tu; Simona Carini; Harold P Lehmann; Brad H Pollock; Mor Peleg; Knut M Wittkowski
Journal:  J Biomed Inform       Date:  2013-11-13       Impact factor: 6.317

Review 5.  Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.

Authors:  Geert Koster; Jørn Wetterslev; Christian Gluud; Jan G Zijlstra; Thomas W L Scheeren; Iwan C C van der Horst; Frederik Keus
Journal:  Intensive Care Med       Date:  2014-12-18       Impact factor: 17.440

6.  A telehealth intervention to promote healthy lifestyles after stroke: The Stroke Coach protocol.

Authors:  Brodie M Sakakibara; Scott A Lear; Susan I Barr; Oscar Benavente; Charlie H Goldsmith; Noah D Silverberg; Jennifer Yao; Janice J Eng
Journal:  Int J Stroke       Date:  2017-09-04       Impact factor: 5.266

Review 7.  Bench-to-Bedside: A Translational Perspective on Murine Models of Sepsis.

Authors:  Anthony J Lewis; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

8.  Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.

Authors:  Jonathan W Waks; Christopher Hamilton; Saumya Das; Ashkan Ehdaie; Jessica Minnier; Sanjiv Narayan; Mark Niebauer; Merritt Raitt; Christine Tompkins; Niraj Varma; Sumeet Chugh; Larisa G Tereshchenko
Journal:  J Interv Card Electrophysiol       Date:  2018-03-14       Impact factor: 1.900

9.  Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer.

Authors:  X Serra-Aracil; A Zárate; L Mora; S Serra-Pla; A Pallisera; J Bonfill; J Bargalló; A Pando; S Delgado; E Balleteros; C Pericay
Journal:  Int J Colorectal Dis       Date:  2018-03-16       Impact factor: 2.571

10.  An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.

Authors:  Lisa Shaw; Nawaraj Bhattarai; Robin Cant; Avril Drummond; Gary A Ford; Anne Forster; Richard Francis; Katie Hills; Denise Howel; Anne Marie Laverty; Christopher McKevitt; Peter McMeekin; Christopher Price; Elaine Stamp; Eleanor Stevens; Luke Vale; Helen Rodgers
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.